Ace inhibitor ramipril is more effective than the β-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (Ramipril cardioprotective evaluation) study

Enrico Agabiti-Rosei, Ettore Ambrosioni, Cesare Dal Palù, M. Lorenza Muiesan, Alberto Zanchetti, A. Zanchetti, C. Cuspidi, A. Libretti, R. Sega, C. Mazzola, C. Piemonti, C. Pasotti, A. Capra, E. Uslenghi, G. Ugliengo, C. Dal Palu, A. Semplicini, P. Maiolino, A. Rossi, P. PascottoD. D’Este, C. Martines, D. Marchese, D. Zanuttini, D. Pavan, P. Zonzin, R. Fiorencis, R. Miori, G. De Venuto, D. Brachetti, U. De Castro, A. Brunelli, A. Alboni, F. Ippolito, G. Tumiotto, S. Bosi, C. Guadagni, R. Agosta

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Ace inhibitor ramipril is more effective than the β-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (Ramipril cardioprotective evaluation) study'. Together they form a unique fingerprint.

Medicine & Life Sciences